The novel coronavirus disease (COVID-19) pandemic has resulted in over 750 million confirmed cases since its emergence. There has been growing attention towards long-COVID or post-acute sequelae of COVID-19 (herein referred to as PASC), which refers to persisting symptoms after the resolution of the acute infection. With the prevalence of PASC estimated to be as high as 65 million globally, there is a heightened urgency to improve our understanding of its etiology to guide management [1]. Reports of autonomic dysfunction or dysautonomia in those with PASC are emerging in the literature [1–4].
